Exact Mass: 485.9405

Exact Mass Matches: 485.9405

Found 21 metabolites which its exact mass value is equals to given mass value 485.9405, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5-Fluorodeoxyuridine triphosphate

5-Fluorodeoxyuridine triphosphate

C9H14FN2O14P3 (485.9642)


   

cis-3,4-Dihydrohamacanthin B

(+)-cis-3,4-Dihydrohamacanthin B

C20H16Br2N4O (485.9691)


   
   

10,11-dihydroomaezallene

10,11-dihydroomaezallene

C15H21Br3O3 (485.9041)


   

cis-3-4-Dihydrohamacanthin B

cis-3-4-Dihydrohamacanthin B

C20H16Br2N4O (485.9691)


   

(E)-6,16,16-tribromohexadeca-5,15-dienoic acid

(E)-6,16,16-tribromohexadeca-5,15-dienoic acid

C16H25Br3O2 (485.9405)


   

Pyrimido[4,5-g]quinazoline-4,9-dione,2,7-bis(bromomethyl)-3,8-dihydro-5,10-dimethoxy-3,8-dimethyl-

Pyrimido[4,5-g]quinazoline-4,9-dione,2,7-bis(bromomethyl)-3,8-dihydro-5,10-dimethoxy-3,8-dimethyl-

C16H16Br2N4O4 (485.9538)


   

1-[(2-bromo-1-adamantyl)methyl]-4-methyl-piperazine dihydrobromide

1-[(2-bromo-1-adamantyl)methyl]-4-methyl-piperazine dihydrobromide

C16H29Br3N2 (485.9881)


   

Aluminum hexafluorosilicate

Aluminum hexafluorosilicate

Al2F18H6Si3 (485.9121)


   

Neltenexine

Neltenexine

C18H20Br2N2O2S (485.9612)


R - Respiratory system > R05 - Cough and cold preparations > R05C - Expectorants, excl. combinations with cough suppressants > R05CB - Mucolytics C78273 - Agent Affecting Respiratory System > C74536 - Mucolytic Agent

   

Nonadecafluorononan-1-ol

Nonadecafluorononan-1-ol

C9HF19O (485.9724)


   

(2r,3ar,5s,7s,8r,9ar)-7-bromo-2-[(1r)-1-bromoprop-2-yn-1-yl]-5-[(1s)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocin-8-ol

(2r,3ar,5s,7s,8r,9ar)-7-bromo-2-[(1r)-1-bromoprop-2-yn-1-yl]-5-[(1s)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocin-8-ol

C15H21Br3O3 (485.9041)


   

7-bromo-2-(3-bromopropa-1,2-dien-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocin-8-ol

7-bromo-2-(3-bromopropa-1,2-dien-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocin-8-ol

C15H21Br3O3 (485.9041)


   

(2r,3as,5r,7s,8r,9as)-7-bromo-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1s)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocin-8-ol

(2r,3as,5r,7s,8r,9as)-7-bromo-2-(3-bromopropa-1,2-dien-1-yl)-5-[(1s)-1-bromopropyl]-octahydro-2h-furo[3,2-b]oxocin-8-ol

C15H21Br3O3 (485.9041)


   

2-{[3-bromo-5-(1-bromopropyl)oxolan-2-yl]methyl}-5-(1-bromoprop-2-yn-1-yl)oxolan-3-ol

2-{[3-bromo-5-(1-bromopropyl)oxolan-2-yl]methyl}-5-(1-bromoprop-2-yn-1-yl)oxolan-3-ol

C15H21Br3O3 (485.9041)


   

7-bromo-2-(1-bromoprop-2-yn-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocin-8-ol

7-bromo-2-(1-bromoprop-2-yn-1-yl)-5-(1-bromopropyl)-octahydro-2h-furo[3,2-b]oxocin-8-ol

C15H21Br3O3 (485.9041)


   

(2r,3r,5r)-5-[(1r)-1-bromoprop-2-yn-1-yl]-2-{[(2s,3s,5s,6r)-3,5-dibromo-6-ethyloxan-2-yl]methyl}oxolan-3-ol

(2r,3r,5r)-5-[(1r)-1-bromoprop-2-yn-1-yl]-2-{[(2s,3s,5s,6r)-3,5-dibromo-6-ethyloxan-2-yl]methyl}oxolan-3-ol

C15H21Br3O3 (485.9041)


   

(3s,5r)-3,5-bis(6-bromo-1h-indol-3-yl)-3,4,5,6-tetrahydropyrazin-2-ol

(3s,5r)-3,5-bis(6-bromo-1h-indol-3-yl)-3,4,5,6-tetrahydropyrazin-2-ol

C20H16Br2N4O (485.9691)


   

(2r,3r,5r)-2-{[(2s,3s,5r)-3-bromo-5-[(1r)-1-bromopropyl]oxolan-2-yl]methyl}-5-[(1r)-1-bromoprop-2-yn-1-yl]oxolan-3-ol

(2r,3r,5r)-2-{[(2s,3s,5r)-3-bromo-5-[(1r)-1-bromopropyl]oxolan-2-yl]methyl}-5-[(1r)-1-bromoprop-2-yn-1-yl]oxolan-3-ol

C15H21Br3O3 (485.9041)


   

5-(1-bromoprop-2-yn-1-yl)-2-[(3,5-dibromo-6-ethyloxan-2-yl)methyl]oxolan-3-ol

5-(1-bromoprop-2-yn-1-yl)-2-[(3,5-dibromo-6-ethyloxan-2-yl)methyl]oxolan-3-ol

C15H21Br3O3 (485.9041)